Autonomix Medical, Inc. is a medical technology company focused on developing breakthrough technology for the nervous system. Their innovative approach aims to provide clearer visibility into the nervous system, enabling new treatments and diagnostic techniques. With a leadership team experienced in building successful medical companies, Autonomix is poised to make significant advancements in the field.

Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize the way diseases involving the peripheral nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times greater sensitivity than currently available technologies.  We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.   

We are initially developing our technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

Autonomix Medical

Autonomix is positioned to be a major player in the #electrophysiology field. We’re developing technology that we believe will make new treatments possible in the lives of patients suffering with a variety of medical conditions.

https://bit.ly/3SQvNWe  
#DetectionTechnology

Our Executive Chairman, Walter Klemp, dives in to the exciting Autonomix opportunity. Access the full video here: https://bit.ly/3Mb9Ih1 

#PancreaticCancer #Electrophysiology #MedTech #NeuralSignals

Autonomix Medical, Inc. to Present at the Virtual Investor Event Titled “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System” 

https://bit.ly/4a0iyIC 
#Electrophysiology #MedTech #NeuralSignals
#DetectionTechnology

We are developing an innovative technology designed to detect malfunctioning #neuralsignals and ablate nerves in a procedure for pain management.

https://bit.ly/3SQvNWe 
#Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals
#DetectionTechnology

Dive in to how our technology works here: https://bit.ly/3rPabi5  

#Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals
#DetectionTechnology

Wishing you a very Happy Thanksgiving from all of us at Autonomix!

Our mission is to dramatically improve the quality of millions of lives by empowering the nerve-targeted treatments of tomorrow. 

https://bit.ly/3rPabi5  
#Electrophysiology #MedTech #NeuralSignals

Its #WorldPancreaticCancerDay! Today we shine a light on those who fought their battle, those still fighting, their loved ones and communities around the world.

#PancreaticCancer #Electrophysiology #MedTech #NeuralSignals

Our Executive Chairman, Walter Klemp, dives into the exciting Autonomix opportunity. Access the full video here: https://bit.ly/3Mb9Ih1 

#PancreaticCancer #Electrophysiology #MedTech #NeuralSignals

Our dedicated team has over 50 years of experience in the medical device world and have developed a number of technologies that are already impacting people’s lives. 

https://bit.ly/45DQS9b  
#Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals
#DetectionTechnology

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

AMIX

COM:AUTONOMIX

Autonomix Medical, Inc.

Last Close

0.59

30/08 20:00

Market Cap

10.17M

Beta: -

Volume Today

4.16M

Avg: -

Analysis Not Available